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Human Studies on the Association of Cellular Immune
Factors in TrachomaWith Infection and Disease.
LD Bobo*,NG Novak, S Vitale. H Mkocha,Y-H Hsieh,
B Munoz, S West,TC Quinn
Infectious Diseases and Dana Center, Johns Hopkins
University, BaltimoreMD
Introduction
Trachoma, which is causedby Clamydia trachomatis,
is the most common cause of infectious blindness in the
world, with cases predicted to exceed 12 million within the
next 30 years (1). Most children living in Tanzanian vil-
lages where trachoma is endemic experience chlamydia
ocular infection with prevalence ranging from 40-60%. In
general, infection prevalence is lower in adults, but the
severe scarfing sequelae, trichiasis, is more prevalent in
women suggesting a higher infection rate. A delayed-type
hypersensitivity response to reinfection is thought to par-
ticipate in the development of pathology, however the un-
derlying mechanism is not clear (2). Although chlamydia
infection prevalence is higher in children, we have identi-
fied subgroups which have either severe disease in the ab-
sence of risk factors, such as, unclean faces, versus those
who clear infection with minimal disease. It is thus impor-
tant to compare immunogenetic as well as socio-environ-
mental differences between people who differ in their abil-
ity to clear infection and in their pathologic response to
infection.
Trachoma is a useful model for these comparisons.
Clinical scoring of disease severity and ocular samples are
easily obtained by field personnel without using invasive
procedures. These attributes would be useful in longitudi-
nal studies with serial samplings for determining a specific
immune response associated with onset and clearance of
infections or development and resolution of disease. Be-
cause of the important immunoregulatory and pathogenic
role of cytokines in other infectious diseases the following
studies deal with the local cytokine response associated
with C. trachomatis ocular infection and disease severity.
In addition, we discuss the diversity ofomp-1 genovariants
in our study population as suggestive that other
immunointervention strategies should be considered.
Cytokine Studies
Using cross-sectionally obtained samples, we com-
pared the types and levels of cytokine mRNA from
conjuctival cells and of cytokine protein from tears with
infection status and disease presentation. We chose to mea-
sure those mediators which are involved in the Thl/Th2
paradigm, or which are known to be proinflammatory or
cicatrogenic. The population for themRNA study was com-
posed of50 adults and children living in trachoma-endemic
villages in central Tanzania. Disease was scored using the
WHO grading scheme of trachomatous inflammation ob-
scuring at least 50% oftarsal vessels (TI), the presence of 5
follicles (TF), TI and any scarfing (TIC), scarfing only (TC),
and no disease signs in either eye (NS). Chlamydial DNA
was detected by PCR-EIA (3), and mRNA was measured
using RT-PCR-EIA with amplifiedDNA levels expressed as
log fluorescence units (4). Sample cDNAs were standard-
ized to each other according to I]-actin level.
As in previous studies, we found that chlamydialDNA
load was higher in the presence ofinflammation: TI, 2.31 +
0.35; TF, 1.61 +/-0.18; TIC, 2.02 +/- 0.24; TC, 1.41 +/-0.22; and
NS, 0.8 +/- 0.11. In Figure infection status is compared to
transcripts levels, with boxes encompassing 75% ofthe data,
and medians indicated by a horizontal line within the box.
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FIGURE I (modified) (4).
An asterisk at the bottom of the box indicates that the me-
dian was at the lowest point ofthe box. Chlamydia positiv-
ity is indicated with a clear box, and a gray box indicates
no chlamydia. A (t) indicates a level of significance ofp <
0.05, whereas (:[:) indicates p < 0.001.
In Figure 2, clinical disease score is compared to tran-
scripts and the same conventions are use as in Figure 1.
Symbols for disease score are included in Figure 2. TGF-]] 1,
TNF-, and IFN-ywere significantly elevated in the TI group
(p < 0.001), as well as for TF compared to NS (p < 0.05).
TGF-I] was significantly elevated (p< 0.05) for TIC orTC
compared to NS. IL-2 and IL-12p40 were significantly el-
evated for TI (p < 0.05). IL-12p40 was significantly associ-
ated with IFN-y (p < 0.003). Although IL-12p40 was not
significantly associated with chlamydia infection (6/10 with
chlamydia and IL-12), all 10 people were in the TI/TF cat-
egory. IL-2 was more likely to occur with IFN-y and IL-12
(p < 0.001). IL-4,5 and 10 transcripts were not found in any
samples, and IL-6 mRNA was detected in only 2 people
with TI. Elevated ICAM-1 (not shown), was highly associ-
ated with infection and TI (p < 0.05). CD3-5 T cell receptor
transcripts were elevated in all disease categories as com-
pared toNS.
Tear cytokines from 36 children were measured by
ELISA. Eighteen children had chlamydia infection by PCR-
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EIA. There were 12 in each clinical category ofTI, TF, orNS
with 6 chlamydia-positive and 6 chlamydia-negative. There
was a significant association of IL-1 and IL-6 with TI (p
<0.001) regardless of infection stares, but mean levels (pg/
ml) for IL-1 were higher in the presence ofchlamydia in-
fection (7.5 IFN-+ 1.24 compared to 2.5-+1.51). Only one
child with NS had IL-1 and IL-6 but also had chlamydia.
TNF-cz was found in 3 people with TI, and IFN-7 in only 2
persons who had TI and chlamydia. IL-12p40 was found in
50% ofpeople with TI or TF, regardless ofinfection status.
IL-4 was not detected. IL-2, IL-10, and TGF-I were not
measured.
In summary, cytokinemRNA levels were higherwhen
chlamydiawas present as was IL- protein. Highest chlamy-
dialDNA levels were associated with inflammation (TI and
TIC). The cytokine response was predominantly pro-inflam-
matory with respect to IL- [, IL-6, TNF-cx, IFN-7, andTGF-
1. Some mediators ofthe Thl response (IL-2 and IL-12p40)
were only associated with the earlier disease presentations
ofTI or TF, but not with scarring. TGF-131, which is impor-
tant in wound healing but can induce pathogenic scarring,
was elevated in the presence ofinfectious sequelae TC and
TIC. TNF-cx levels were most highly associated with TI, TF,
and TIC with chlamydia positivity. We were unable to de-
fine the role oflFN-yin protection or persistence since IFN-
7was occasionally present with NS and chlamydial DNA.
The finding ofhigher IFN-7and TNF-cx with low IL-2 indi-
cates that natural killer cells should be considered as a po-
tentially important source of these cytokines. Although
CD3q5 transcripts were elevated in disease states, we did
not detect the Th2 mediator, IL-4, by any method. On the
other hand, another Th2 effector, IL-6 protein, was highly
associated with TI/TF, whereas mRNA was infrequently
found. Due to the cross-sectional nature ofthese studies, we
were not able to say with certainty if a particular cytokine
pattern was characteristic of resolution of infection or pro-
tection from disease.
Longitudinal Stud)" of Infection Duration
One purpose of this study was to determine if infec-
tion duration varies between children who have similar
socio-environmental risk factors. The study included 54
children aged 1-12 years from one village in Tanzania who
had clinical disease scores and conjuctival swabs taken
weekly for 3 months (n=632). This set included 12 families
with 30 siblings. Persistent chlamydialDNAby ligase chain
reaction (LCR) was found for 10-12 weeks in 37% (20/54),
with 19/21 infected on week 12. Two children were infected
on weeks 11-12 and 6-12. One child was infected at weeks
3,5, and 7-9. Eleven children (20.4%) were infected at one
or 2 week intervals during the 12 weeks. The remaining 18
(33.3%) did not have chlamydia infection. In terms of re-
lated individuals, all siblings were persistently infected in
25% of families, in another 25% one sibling was persis-
tently infected with the others sporadically or uninfected,
and 25% had one sib sporadically infected with the other
sibs sporadically or not infected.
As in earlier studies, chlamydia positivity was higher
in the TI group (62.7%) compared to TF (42.6%) and NS
(10.4%). In addition, the chlamydial load was higher in
association with TI (2.29 + 0.35), and NS (0.51 +0.12) as
expressed by the LCR ratio (positives are z 1). Children
who were persistently infected generally had high chlamy-
dial loads (>2) in association with TI, whereas sporadically
infected children usually had LCR ratios of between 1-2
and had NS. Neither gender nor a particular age grouping
were significantly associated with increased chlamydial in-
fection or disease presentation although there was a trend
for more females to be infected p 0.142 (OR 0.41, 95%
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CI, 0.33-28.44).
In summary, this data indicates that 1) infection dura-
tion subgroups could be identified as "persistent" or "spo-
radic"; 2) due to the effects of truncation we could not
determine the true duration of infection but that approxi-
mately 40% may have been persistently infected beyond
12 weeks; 3) siblings did not necessarily share the same
infection pattern; 4) chlamydial load was highest in chil-
dren who were in the "persistent" infection group; 5) there
was a trend for more females to be infected than males, but
the difference was not statistically significant.
OMP-I Sequencing Studies
The purposes of these studies were to determine 1)
what the diversity of ocular omp-1 genovariants in central
Tanzanian villages was from 1986-1995, 2) ifthere was any
correlation of a genovariant with infection duration of dis-
ease severity, and 3) if the same person sampled at 2 time
points (1989 and 1995) had the same genovariant. We se-
quenced amplified omp -1 chlamydial DNA scraped from
DFA slides made from conjuctival samples of 74 children
dispersed among 9 villages in 1986 and compared se-
quences to reference strains. In summary, Tanzanian vil-
lages had a diversity ofgenovariants; serovarA 19; B 7;
Ba 3; C 1; D 2, E 2; and F 1. The diversity in any
village ranged form 3-9 genovariants. Both mixed genovar
(26%) and mixed serovar (2.7%) infection (A/E, A/F) were
found. Genovariants possessed "signature" substitutions
in VS1 and 2, and 2.7% had amino acid substitutions in
known B cell neutralizing epitopes. For 9 children who
were sampled in 1989 and 1995, 6 had the same serovar at
2 time points but only 2 had the same genovariant, and
mixed serovar infection occurred (A/B). In the previous
"Longitudinal Study of Infection Duration," persistently
infected children had the same genovariant throughout as
did those who were intermittently infected. Children within
a family had the same genovariant. In addition, there was
no particular association of a genovariant with infection
duration. Finally, we have not found a significant associa-
tion of an omp-1 genovariant with disease severity in any
of our studies.
Conclusions
We have presented the results of substudies dealing
with local cellular immune response, infection duration,
and omp-1 DNA sequencing of C. trachomatis from people
living in trachoma endemic communities. We feel that this
data is consistent with the hypothesis that there are some
people who are persistently infected or get reinfected con-
tinuously, and that they characteristically have higher C.
trachomatis burden and suffer more intense disease. In ad-
dition, since the presence ofchlamydial organisms is asso-
ciated with the highest levels of certain inflammatory and
cicatrogenic cytokines, the sequelae of severe scarfing and
trichiasis are likely to occur as a result. Chlamydia-associ-
ated components which stimulate harmful cellular media-
tors are likely to be common to all C. trachomatis, strains,
such as heat shock protein or another candidate. It is not
known whether cross-stimulation ofthe immune system by
chlamydial hsp and human hsp could amplify the effects of
infection in some hosts. The inability to clear infection of
the occurrence of intermittent re-infection (separated by
weeks or years) with the same genovariant suggests that the
cytokine response to chlamydia infection could be inap-
propriate for maintenance ofimmunity, and that some other
additional factor in a successful host determines rapid clear-
ance and protection from disease. To gain a clearer under-
standing of what controls chlamydial clearance, we will
compare socio-environmental risk factors with infection
duration and disease intensity subgroups in families (moth-
ers and siblings), and in women with trichiasis with local
cytokine and peripheral mononuclear cell response to
chlamydial antigens and with HLA haplotype.
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Antigen and Isotype Specificity of Human B Cell
Responses in Immunopathogenesis of Genital Chlamydia
trachomatJs Infection
S Ghaem-Maghami, PE Hay, DJM Lewis
St George’s Hospital Medical School, London, UK
Mucosal infection with Chlamydia trachomatis (C.
trachomatis) is the most common sexually transmitted dis-
ease and a cause of infertility, ectopic pregnancy, and
perinatal morbidity.
Objectives
To characterise Chlamydia trachomatis-specific B cell
response to human genital infection, in terms of relative
magnitude of antibody class, kinetics of response and
immunodominance of chlamydial antigens at different
stages of disease and treatment.
Methods
We have employed the cell based enzyme linked
immunospot assay (ELISPOT) to characterise trafficking B
cell response during human genital chlamydial infections
by detecting antibody secreting cells (ASCs) spontaneously
secreting IgG, IgA, and IgM antibodies against C.
trachomatis antigens. We have studied a total of 36 men
and 20 women treated for chlamydial infection and 23 con-
trois (healthy asymptomatic men and women). No ASCs
have been seen in any of the 23 controls. In keeping with
"mucosal compartmentalisation," IgA was the predominant
isotype secreted by trafficking anti-EB ASCs in men with
uncomplicated non gonococcal urethritis (NGU) andwomen
with cervicitis (Fig. 1). However, in subjects with extragenital
manifestations (arthritis/conjunctivitis) there was an appar-
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ent break down in the compartment and a relatively in-
creased IgGASC response and decreased IgAASC response.
Results
By employing ELISPOT and using whole Chlamydia
organisms, recombinant proteins and separated antigens,
we have characterized kinetics and antigenic
immunodominance of response. We have studied 25 pa-
tients with whole chlamydia elementary bodies and recom-
binant hsp60, MOMP, and pgp3 and been able to illustrate
relative antigen immunodominance between IgG and IgA.
There is no association between IgAASC response to hsp60
and immunopathology but IgG ASC response to this anti-
gen needs to be investigated in patients with "complex"
disease as preliminary results indicate a relative switch to
IgG ASC response to hsp60 in these patients.
We have characterised the kinetics of the response at
different times after presentation, when two weeks antibi-
otic treatment is commenced. Although patients were at
different stages at presentation, peak trafficking ASCs oc-
cur around 1-2 weeks after treatment, disappearing from the
circulation 3-4 weeks later. Mucosal B cells have been di-
Such data on the characterisation ofhuman B cellular
mucosal/systemic responses to C. trachomatis and their
evolution into disease pathogenesis is a useful model of
genital mucosal systemic infection, with implications for
understanding immunopathology and for delivery ofnovel
human vaccines.
Repetitive Extragenic Palindromic Sequence
Polymorphism Based Polymerase Chain Reaction (rep-
PCR) is a Useful Tool in Diagnostics of Chlarnydia psittaci
Infection in Sheep and in Studies of Field and Vaccinial
Chlarnydial Strains
SP Martinov, E Tcherneva, B JerseW
Central Veterinary Research Institute, Sofia, Bulgaria,
eBiotechnological Faculty of University ofLjubljana,
Slovenia
The aim of the present work is to prepare and test
vaccines against ovine chlamydial abortion and the inves-
tigation ofvaccinial and field strains of Chlamydia psittaci
of different origin by rep-PCR.
During the last ten years three inactivated vaccines
rectly studied using cervical biopsies and urine and results PM-1, PM-2, and PM-3 were prepared against chlamydial
compared with blood. Trafficking IgAASCs are far less fre- abortion in sheep (1,2,3). The methods employed included:
quent than in the mucosa but the pattern of antigenic speci- chicken embryos, cell cultures, electron microscopy (EM),
ficity is very similar suggesting homing of ASCs to mu-
cosal sites. (Fig. 2).
Conclusion
IgA is the predominant antibody produced in response
to an uncomplicated chlamydial genital infection with a
relative switch to systemic IgG activation when there are
extra-genital manifestations ofthe infection. There is a rise
in the number of ASCs immediately following treatment
suggesting increased antigen preser.tation. The circulating
B cell response to Chlamydia infection is tightly controlled,
disappearing from the circulation a few weeks after treat-
ment indicating that the presence of Chlamydia-specific B
cells in the circulation represents acute infection. Using the
ELISPOT technique it is possible to define B cellular im-
mune responses to chlamydial antigens in patients with
different manifestations of chlamydial diseases. This will
clarify the role of these antigens at different stages of dis-
ease and its complications.
mechanical chomogenization, purification, formaldehyde
inactivation, aluminum hydroxide adsorption, sonication,
complement fixation test (CFT), enzyme immunoassay
(ELISA), serum neutralization assay (SNA), polyacrylamide
gel electrophoresis (PAGE), Western blot, checking for ste-
rility and immunogenicity by challenge with live Chlamy-
diae at 85 day of gestation. Strains GV, P, Kt, D (vaccines
PM-1 and PM-2) and A22 and $26/3 (vaccine PM-3) of C.
psittaci, psittaci var.ovis were used and all the stages ofthe
vaccine preparation were checked by EM of negatively
stained suspensions (Fig. 1). The vaccines were concen-
trated and purified. They possessed a high content ofchlamy-
dial antigen measured by CFT and ELISA (5885 IFU/ml at
1:50 dilution of PM-3).
The major outer membrane protein (MOMP) was re-
vealed in the purified chlamydial suspensions by PAGE-
immunoblotting (Fig.2, pattern marked with arrow). The
vaccines were areactogenic and completely innocuous for
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guinea pigs and sheep. They induced considerable sero-
logical response (CFT, ELISA, SNA) for at least 10 months
after single or double immunization with 0.75-1.0 ml s.c.
Table 1 shows a very good response with CFT. The results
from the SNA performed with sera from sheep vaccinated
with PM-3 are presented in Table 2. It is seen that the level
of reduction of the infectiousness determined by the sera,
grows during the second month. Between months 2 and 3
this percentage (i.e., the level ofimmunity) decreases and it
grows up again at the beginning of month 4, and it pre-
serves a stable high level (months 4 and 5). Generally the
vaccine produced a good immune response checkedby SNA.
The challenge experiment consisted of a single immunization
Figure
of 10 pregnant ewes with PM-3 vaccine and challenging them
and 19 unvaccinated controlsmore with a two-straininnoculum
(A22 and $26/3) containing 106 ELDs0. Table 3 presents the
f’mdings in regard to lambing and abortions. None ofthe vac-
cinated ewes aborted. Only one placenta appearedmacroscopi-
tally abnormal and only two sheep yielded Chlamidiae from
the placenta. In contrast there were 11 abortions and 16 dead
animals from 28 in the control group. 15 of all the placentas
tested were gravely affected and in 15 ofthe animals chlamy-
dial excretions were found.
Table I. Chlamydial CF-Antibodies in the Blood Sera of Sheep After
Immunization with Vaccine PM-3
Terma S.I.b CFT (+) MGT D.I.c CFT (+)MGT MGTd
1.5 14 14/100 17.1 13 13/100 18.4 17.8
2.5 14 14/100 64 13 13/100 60 64
3 14 14/100 112 13 13/100 94 104
3.5 14 14/100 120 13 13/100 94 104
4 14 14/100 69 13 13/100 74 69
7 14 12/85.7 13.9 13 1/84.6 19.2 1.3
0 14 I/78.5 4.6 13 8/61.5 3.2 4.0
a Term of testing in months.
b Single immunization.
c Double immunization.
d IIGT; management for both groups.
The experiment with the animals used in the control
group proved they were susceptible to the challenge ap-
plied. The vaccine PM-3 protected the animals against this
challenge and offered a solid immunity and protection af-
ter single or double immunization with PM-3. The experi-
ence ofours shows a real possibility for successful develop-
ment ofChlamidial vaccine for sheep. The investigation of
the chlamydial genome was of interest to us in connection
with choice ofsuitable vaccinial strains.We compared some
of our vaccinial Chlamydia psittaci with field chlamydial
strains by the use ofrep-PCR fingerprinting. Recently, short
interspaced repetitive DNA sequences such as repetitive
extragenic palindromic (REP) sequences or enterobacterial
repetitive intergenic consensus (ERIC) sequences have been
shown to be useful in the study of epidemiology (4,5,6,7).
REP and ERIC sequences have common characteristics such
as highly conserved central inverted repeats and locations
in extragenic regions, but differ in sequence size (REP se-
Figure 2
quences-38 nucleotides; ERIC sequences-126 nucleotides)
and copy number. These short repetitive sequences have
been used for epidemiological studies in a method called
repetitive element sequence basedPCR (rep-PCR) byWoods
et al. (8). In this paper we report the use or rep-PCR to
distinguish among 8 C. psittaci isolates from sheep (4 of
them in the composition ofvaccines described) and to com-
pare them with C. trachomatis- strains isolated from other
animals and 4 C. trachomatis-human isolates. The method
of amplification and the oligonucleotides used were ex-
actly those described by Verasalovic et al., (9). Figure 3A
shows the electrophoresis of rep-PCR amplified products
from Chlamydia ofdifferent origin. All ofthe tested "sheep"
strains possessed 21 different bands with sizes between 400
and 2100 bp (lines 8-15). Some of the bands were more
intense than others. Strains GV (line 13) and P (line 14)
were in the composition ofvaccines PM-1 and PM-2. They
have 4 common bands of 750, 1200, 1600, and 2100 bp.
The strains A22 (line 11) and $26/3 (line 12) composed the
vaccine strains PM 3. These two strains have 4 sharp com-
mon bands, (450, 1200, 1500, and 1600 bp) and 5 common
bands between 550 and 800 bp with less sharpness. These
four vaccinial strains possessed more or less similar finger-
prints with the other C. psittaci isolated from sheep (lines
9,10,15,16). Theyhave some common bands with the strains
isolated from birds and dog (1.1-8) and C. trachomatis (Fig.
3B, 1.8-11) isolated from human (600 bp) as well as C.
psittaci isolated from pigs (1. 12,13). In all of the tested
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Table 2. Bulgarian Vaccine Group Serum Neutralization Assay"
Ewe No. Nov 24 Dec 22
% Infectivity reduction.produced by serum from:
Janl0 Febl6 Marl Marl6 Aprl3
Lambed
orAborted
C. psittaci
positive
DPV 0 28 56 84 97 112 140
DPI -102 174 -46 -10 -5 10 381
2080 6 98 100 45 46 70 52 67 L
2094 0 33 50 7 12 32 44 73 L
2157 0 100 100 57 19 23 74 L
2172 0 94 100 0 15 68 48 82 L
2178 60 96 76 56 57 37 54 99 L
2189 0 100 100 32 63 56 29 100 L
2220* 0 NS 100 0 27 39 25 0 A"
2232 0 100 85 5 51 0 19 83 L
2247 0 58 89 3 13 56 58 100 L
2259 0 42 97 39 NS 57 67 100 L
Mean 6.6 80.1 89.7 18.8 37.9 43.4 41.9 77.8
(+/- SD) 18.9 27.6 16.2 21.7 21.0 22.3 16.7 30.1
"DPV: Days post vaccination; DPI: Days post infection, NS" no sample; L/A-Lambing or Abortion, +: Diagnosis of C. psittaci.
Table 3. Treatment: BulgarianVaccine
% Placenta Chlamydia AFBs in smears
Ewe # ELD L/A GL Live LBD Dead affected smear culture vs pla
2080 6/5 L5/5 145 0 0 0
2094 6/5 L 1/5 141 0 0 50
2157 7/5 L 1/5 140 0 0 0
2172 6/5 L 11/5 151 0 0 0
2178 6/5 L5/5 145 0 0 0
2189 7/5 L7/5 146 0 0 0
2220* 6/5 A 17/4" 127" 0 ?*
2232 6/5 L6/5 146 0 0 0
2247 6/5 L9/5 149 0 0 0
2259 9/5 L 10/5 147 0 0 0
+ +
+ +
9 A 0 145.6 9 0 0 N grossly
(excl. 2220) L 9 +/-SD 3.47 affected 1/9
+/-SE 1.16 0 x 6%
2 2 0
2
+: Lambs dying within 2 days ofbirth due to general weakness; **: Estimated by eye; ELD: Expected lambing date; GL:
Actual gestation length; AFBs: Acid fast bacilli (C. burnetii) L: Lambed; A: Aborted (at lease one lamb born dead or
dying within 2 d ofgeneral weakness); LBD: live but died; vs: vaginal swab; pla: placenta; *: excluded from analyses due
to indication that the cause of abortion was not C. psittaci; ?: Placenta grossly abnormal, but proportion affected difficult
to assess.
strains we can see different polymorphic bands, typical for
every strain. ERIC-PCR resulted a band of300 bp common
for all of the tested strains. This band can be like a marker
for Chlamidiae in the diagnostic process. ERIC-PCR is less
discriminating than rep-PCR concerning the vaccinial
strains. For all the strains tested "ERIC-bands" are about
19. Only 5 ofthem are sharp enough for comparison. Two of
these bands (300 and 850 bp) are possessed by A22 and
$26/3 and 5 (400, 500, 700, 850, and 1400 bp) could be
seen inGV and P strains. The reproducibility ofthe method
is excellent since the same results were obtained by mul-
tiple amplifications ofthe differentDNA preparations. Clus-
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ter analysis provided byUPIGMA and Jacard coefficient of
rep-PCR (Fig. 4) showed more than 80% similarity of
vaccinial strains with the other C. psittaci isolated from
sheep and more the 60% similarity with C. psittaci isolated
from other animals. The cluster analysis of the 4 C.
trachomatis strains showed completely different for these
strains.
In conclusion, rep-PCR, which is a versatile method
to distinguish related bacterial strains, appears to be appli-
cable for C. psittaci. It is simple and sensitive techniques
for the investigation of field and vaccinial strains of C.
psittaci.
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Asymptomatic Chlamydia trachomatis
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Women Undergoing InVitro Fertilization
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Objective
C. trachomatis infections of the female genital tract
are often asymptomatic and, therefore, may remain unde-
tected. This organism is a major cause of occlusion of the
fallopian tubes, resulting in infertility or ectopic pregnancy.
Many couples with tubal infertility, as well as infertility
due to other factors, seek to conceive via IVF. The relation
between a past or present chlamydial infection and infertil-
ity has remained controversial. Circulating antibodies to
C. trachomatis have been associated with adverse IVF out-
come in some studies, but not in others. A recent study on
women undergoing IVF in New York City demonstrated
that the presence ofcervical IgA antibodies to C. trachomatis
correlated with poor outcome. To validate and extend these
findings, women undergoing IVF in France were tested for
circulating and cervical antibodies to C. trachomatis and
the results correlated with detection of cervical cytokines,
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clinical findings and IVF outcome.
Methods
At the time ofoocyte retrieval, an endocervical swab
was. obtained from 120 consecutive women and the con-
tents transferred to a tube containing 0.5 ml sterile saline.
Blood was obtained by venipuncture. Serum IgG and IgA
antibodies, and cervical IgA antibodies, to C. trachomatis
were determined by ELISA, using a new commercial kit
specific for C. trachomatis (Savyon Diagnostics, Beer Sheva,
Israel). Interleukin 8 (IL-8), interleukin 10 (IL-10), and in-
terferon gamma (IFNy) in cervical samples were detected
by ELISA.
Results
Anti- C. trachomatis IgA was detected in the cervices
of 14 women (11.7%), 45 (37.5%) women had cervical IL8,
15 (12.5%) were positive for IL10 while 54 (45%) had IFNT.
The presence of cervical anti- C. trachomatis IgA corre-
lated with detection oflL8 (p 0.007) and IFN/(p 0.04).
IL8 was present in 71.4% of women with and 33.0% of
women without anti-chlamydial IgA. Similarly, IFNq( was
detected in 71.4% of women with and 41.5% of women
without antichlamydial IgA. In contrast, there was no rela-
tion between ILl0 and cervical anti-chlamydial IgA. The
presence of IL8 and IFNy in the cervix was highly corre-
lated (p 0.0001) and unrelated to the presence ofIL10. In
marked contrast, there was no relation between circulating
anti-chlamydial antibodies and cervical cytokines. In ad-
dition, cervical IgA antibodies to C. trachomatis were unre-
lated to the presence ofcirculating anti- C. traahomatis IgG
or IgA antibodies. This emphasizes that the cervical IgA
antibodies detected were produced locally. As expected,
women with occluded or functionally altered fallopian tubes
had a higher prevalence of systemic antichlamydial IgG
than didwomen whose infertility was due to other causes (p
0.0009). However, there was no association between cer-
vical anti-chlamydial IgA and cause of infertility. Ongoing
pregnancies were documented in 2 (14.3%) women with
cervical antichlamydial IgA and in 14 (15.4%) womenwho
lacked this antibody. Similarly, ongoing pregnancies were
present in 4 (21%) women with, and in 12 (14%) women
without, circulating antichlamydial IgG.
Conclusions
The association between cervical IgA antibodies to
C. trachomatis and the presence of IL-8 and IFN’ at this
site strongly suggests that measurement ofthese antibodies
identified the presence ofan active inflammatory-inducing
infection. In the absence of detectable C. trachomatis the
possibility of a persistent intracellular infection in these
women must be considered. In contrast, detection of circu-
lating anti-chlamydial antibodies merely indicated past ex-
posure to this organism. Additional subjects need to be
evaluated before the relation between cervical anti-chlamy-
dial igA and IVF outcome can be evaluated in this popula-
tion.
Prevalence of Chlamydia trachomatis Antibodies in Cord
Blood
S Djukie,M Nedeljkovic,M Pervulov, S Vesic,A
Ljubic, B Vranes
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Belgrade, Yugoslavia, 2Institute of Gynecology and
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The obligate intracellular bacterium Chlamydia
trachomatis is an important human pathogen responsible
for sexually transmitted diseases throughout the world. This
bacterium is a frequent cause of both complicated and un-
complicated genital tract infection (1).
Many chlamydial infections are asymptomatic or not
easily recognized on clinical grounds alone (2). The dis-
ease process associated with chlamydial infections is
thought to be principally immunologically mediated. Re-
peated episodes of infection clearly play a role in stimulat-
ing the host immune response and enhancing damaging
pathologic changes (3).
Genital chlamydial infections are an important cause
of reproductive morbidity. Various studies have examined
the possible roles of maternal Chlamydia trachomatis in-
fection in adverse pregnancy outcomes. Suggested compli-
cations include premature rupture of membranes, preterm
labor and birth, low birth weight (<2500g), intrauterine
growth retardation and stillbirth, as well as intrapartum and
postpartum maternal and neonatal infectious morbidity
(4,5,6).
The aim of this study was to examine 52 fetal blood
samples obtained during Cesarean section for the presence
of chlamydial IgM and IgG specific antibodies. Pregnant
women between the ages of 17 and 41 years (mean 29.14)
participated in the study. Prior to Cesarean section mother’s
peripheral blood was drawn.
The presence of C. trachomatis IgM specific antibod-
ies in mother and fetal blood samples was determined by
using the indirect immunofluorescence test (Bio-Merieux,
France). Tests were set up and performed according to the
manufacturer’s instructions.
The presence of C. trachomatis IgG was determined
by using the enzyme-linked immunosorbent assay (Orion
Diagnostic, Finland). Tests were set up and performed ac-
cording to the manufacturer’s instructions.
For statistical analysis the Spearman rank correlation
were used. A p value < 0.05 was considered to be statisti-
cally significant.
IgG antibody was detected in 11 of 52 (21.2%) in-
fants. The majority of the IgG-seropositive infants had ti-
ters between 1:64 and 1:128. Peak titers of l:1048and
1:2048 were observed in only 2 ofthe 52 infants. Nineteen
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of the 52 (36.5%) women were IgG seropositive. The
Spearman rank correlation between IgG titer findings in
mother’s and fetal blood was significantly high (r 0.76; p
<0.01).
Nine of52 (17.3%) infants were IgM seropositive. All
samples had IgM antibody titers of 1:16. IgM antibody was
detected in 16 of 52 (30.8 %) women. The Spearman rank
correlation between IgM titer findings in mother’s and fetal
blood was significantly high (r 0.74; p < 0.01).
None ofthe specimens collected in the newborn nurs-
ery (< 3 days ofcare) yielded Chlamydia. These infants had
no clinically detectable disease during the first seven days
oflife.
As it appears that systemic immune function is largely
maintained during gestation, maternal susceptibility to in-
fection and the ability to combat an established infection
should be similar in both the pregnant and nonpregnant
states (7). The circulating B-cell level during gestation is
preserved during pregnancy. Numerous studies show nor-
mal circulating levels oflgG, IgM, and IgA during uncom-
plicated pregnancies (8).
Since only IgG is capable of transplacental passage,
the presence ofchlamydial IgM-specific antibodies in fetal
blood show the intrauterine infection (9). It was shown by
several authors that whether the infection is symptomatic
or asymptomatic, C. trachomatis-infected infants regularly
develop Chlamydia-specific antibody (10).
Our data indicate that there is a high rate oftransmis-
sion ofChlamydia trachomatis from mother to infant, with-
out any clinical symptoms.
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Persistence of Chlamydia trachomatis and Chlamydial
Antigens in HEP-2 and THP- Cells afterTreatment with
Ciprofloxacin
O Dreses-Werr|ngloer, B Jirgens, H Zeidler, L Khler
Dept. ofRheumatology, Medical School Hannover,
Germany
Objective
Chronic chlamydial diseases such as Chlamydia-in-
duced arthritis are characterized by persistence of Chlamy-
dia trachomatis (CT) in a culture-negative, nucleic acid-
positive, metabolically active and viable state at the site of
inflammation in mononuclear cells and synovial fibroblasts.
Although in one study the duration of early Chlamydia-
induced arthritis was shortened by antibiotic treatment (1),
other clinical trials using antibiotics even over a prolonged
period failed to alter the course of the joint disease (2).
Therefore, we started a program to investigate the effect of
antibiotics on the low-productivity infection in the mono-
cytic cell line THP-1 in comparison to the replicative-pro-
ductivity infection in HEp-2 cells. Here, we describe the
results with ciprofloxacin, one antibiotic in use for acute
and chronic urogenital chlamydial infections.
Methods
HEp-2 monolayers and 12-O-tetradecanoylphorbol-
13-acetate (TPA)-differentiatedTHP- cells were inoculated
with Chlamydia trachomatis serovar K at a multiplicity of
infection (MOI) of 0.05 and 2, respectively. After centrifu-
gation (15 min, 1500 rpm) and incubation for 2 h at 37 C,
cells were washed three times and cultured 2 or 3 days in
antibiotic-free medium, which contained 0.5 I.tg/ml cyclo-
heximide for HEp-2 cells. Incubation with ciprofloxacin
starting 48 or 72 h post infection (p.i.) was performed con-
tinuously or stopped at times indicated. Infected cells were
harvested over a culture period of 14-20 days.
Immunofluorescence microscopy.
Cytocentrifuge smears of cells were stained with a
FITC-conjugated murine monoclonal antibody, directed
against a common major outer membrane protein (MOMP)
epitope of elementary and reticulate bodies. Samples were
screened with an epifluorescence microscope and inclu-
sion bodies counted.
Infectivity of Chlamydia trachomatis.
Infectivity was determined by titration of cell lysates
on HEp-2 monolayers and subsequent staining of inclu-
sions 48 h p.i. by an immunoperoxidase assay.
Determination of chlamydial rRNA.
Chlamydial rRNA was measured by an in vitro-hy-
bridization assay with a single stranded chemiluminescence
labelled DNA probe.
SDS-PAGfi and immunoblotting
Levels of chlamydial MOMP, lipopolysaccharide
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(LPS), and 60-kDa heat shock protein (hsp60), were exam-
ined by Western blot analysis. Harvested cells were ana-
lyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) (12% or 15% polyacrylamide).
Following electrophoresis and transfer to PVDF-membrane,
proteins were probed with either anti-MOMP, anti-LPS, or
anti-hsp60 antibody.
Results
The minimal inhibitory concentration (MIC) of
ciprofloxacin was determined by simultaneous addition of
CT and the antibiotic to cells. The MIC, defined as the
lowest concentration of drug which inhibited development
of chlamydial inclusion bodies after 48 h, was 0.35 Ixg/ml
for HEp-2 cells and 0.28 I.tg/ml for THP-1 cells.
Two days after inoculation, chlamydia inclusion bod-
ies had evolved in about 1% of HEp-2 cells. Addition of
ciprofloxacin (0.5 I.tg/ml) 2 or 3 days p.i., to the infected
cells led to a continuous decrease of inclusion bodies, in-
fectivity and chlamydial rRNA. Despite the loss ofchlamy-
dial infectivity by 10 days p.i., inclusions and rRNA were
detectable during further treatment until 20 days after in-
fection. Levels ofchlamydial MOMP, LPS, and hsp60 were
reduced but still present during the whole culture period.
Even treatment with the higher concentration of 1.0 lxg/ml
starting 48 h after infection did not result in complete eradi-
cation of chlamydia from host cells.
Normal growth of chlamydia was obtained when
ciprofloxacin (0.5 g/ml) was omitted 6 or 7 days p.i. The
removal of the drug 8 days after infection resulted in a
persistent infection, characterized by the maintenance of a
constant number of inclusion bodies, and a slight increase
in infectivity and levels of chlamydial rRNA, LPS, hsp60,
and MOMP.
Inoculation of TPA-differentiated THP-1 cells with
CT resulted in a low-productivity infection. In about 0.3-
0.5% of the cells inclusion bodies were demonstrated 48 h
after infection. Treatment with ciprofloxacin (0.3 I.tg/ml)
starting 2 or 3 days postinfection significantly diminished
the number of inclusions and chlamydial infectivity. After
9 or 10 days (= 12 days p.i.), according to the time
ciprofloxacin had been added, no typical inclusions were
seen. Loss ofchlamydial infectivity had already occurred 7
or 8 days p.i. Although no chlamydial inclusions and infec-
tivity were present, single chlamydial particles, LPS, and
hsp60 were detected over the whole culture period of 14
days. Even exposure to a higher concentration (0.5 tg/ml)
did not lead to complete eradication of chlamydia.
Conclusions
Ciprofloxacin fails to eradicate chlamydia completely
from HEp-2 and THP-1 cells. Although chlamydial growth
is inhibited, inclusions or particles and the antigens LPS,
hsp60, andMOMP persist over a period of20 days in HEP-
2 and 14 days in THP cells. Failure of complete eradica-
tion does not appear to be an effect of a too low concentra-
tion of antibiotic.
Productive infection in HEp-2 cells is changed to a
persistent infection by short-term treatment with
ciprofloxacin.
The in vitro persistence of chlamydial LPS, hsp60,
MOMP, and chlamydial particles in THP-1 and HEp-2 cells
may be ofpathogenetic relevance for in vivo induction and
perpetuation of chronic chlamydial diseases. Further stud-
ies are under way to elaborate the ability of other antibiot-
ics (azithromycin, doxycyclin) to eradicate CT in vitro.
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Failure to Detect C. trachomatis by MOMP PCR, in
Contrast to Cultures with Multiple Passages, In Situ
Hybridization and Immunoperoxidase Staining, In Pelvic
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C. trachomatis detection from pelvic samples in
chronic infection and more particularly tubal factor infer-
tility (TFI) cases is controversial, chlamydial persistence
being supposed to maintain the host immune response.
We obtained, in previously published assays, 30%
positive cultures, and were able to keep 7 isolates, from 18/
58 pelvic samples taken by laparoscopy in 7/21 TFI cases
with positive CT serology. According to the sampled site,
we obtained positive culture in 7/13 (53%) tubal biopsies,
8/21 (38%) adhesion biopsies, 3/13 (23%) tubal smear and
3/17 (17%) peritoneal cul-de-sac fluid (1). Ofthis series, 11
samples from 3 culture positive cases, were testedbyMOMP
PCR, only 3/11 were found positive. In contrast, the iso-
lated strains were found positive, when tested in MOMP
PCR.
In a new series of 146 pelvic samples taken in 55 TFI
cases, all attempts to detect CT by PCR and culture were
negative (2), similar to other authors findings.
Using in situ detection, the presence of chlamydial
DNA in pelvic samples was detected in 1/10 cases by elec-
tron microscopy, 3/29 (10%) by culture, 13/23 (50%) by in
situ hybridization (ISH) and 16/26 (61.5%) by
immunoperoxidase staining (IP) (3).
Objectives
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To compare chlamydial agent detection by MOMP
PCR and other methods.
Material and methods
Nine tubal biopsies taken on 9 pathological tubes,
were studied as follows: 1) cell culture with 7 successive
passages; 2)MOMP PCR; 3) ISH based on a C. trachomatis
7.4 kb plasmid cloned into Ptz 18r digested with Eco R1
and a Ptz 18r digested with Eco R1 as negative control
probe; and 4) IP staining on 4 tm tissue sections, incubated
in unconjugated Chlamydia monoclonal antibody (mAB)
KK-12 at various dilutions. This mAB recognizes a species
specific determinant on the major outer membrane protein
of C. trachomatis.
Results
In this short series, chlamydia detection was positive
in 1/9 cases by ISH, 7/9 cases by IP and in contrast, no case
was positive by PCR nor by culture.
Comments
This assay shows that persistent chlamydial agent in
chronic pelvic female infections is difficult to cultivate
and is not recognized by MOMP PCR. In addition, pelvic
samples probably have PCR inhibitors. Samples were not
processed the sameway forPCR and ISH/IP (tissue process-
ing). Other amplification methods, based on different
epitopes should be of interest in further studies.
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Variability of Non-Culturable Chlamydia trachomatis
Persisting in Human Peripheral Blood Monocytes and
Human MonocyticTHP-I Cells
L Koehled, E Nettelbreked,A Hudson, H Grard, D
BonW, H Zeidler
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Introduction
After urogenital infection with Chlamydia
trachomatis serovar D-K 1-3% of the patients develop a
reactive arthritis. Diagnosis of chlamydia-induced arthritis
is based in part upon detection of various chlamydial mac-
romolecules in synovial fluid and/or synovial membrane,
although the organism can not be grown by standard mi-
crobiological techniques. Intracellular chlamydia have been
demonstrated within monocytes isolated from synovial fluid
and membrane in a culture-negative, nucleic acid positive-
state, even as late as 12 years after onset of the disease.
Culture-negative, nucleic acid-positive chlamydial infec-
tions of the joint have been designated "inapparent" to
suggest that the organism persists at this site in an intact,
possibly viable form. It has been proposed that the persis-
tence of Chlamydia trachomatis in monocytes is relevant
to the pathogenesis of inflammation in chronic chlamydial
diseases. Previously, we have shown that Chlamydia
trachomatis persists in a non-replicative state in human
peripheral blood monocytes and gamma interferon (IFN,)
treated human monocytic THP-1 cells.
Methods
Human peripheral blood monocytes obtained from
healthy donors were prepared by Ficoll gradient centrifu-
gation and vigorous washing. Human monocytic THP-1
cells were differentiated by addition of the phorbol ester
TPA at a concentration of 2 x 10 8M. Chlamydia
trachomatis serovar K was added to the cells at the multi-
plicity ofinfection (MOI) of 1. THP-1 cells were incubated
with or without IFNy 24 h prior to infection. Chlamydia
trachomatis -infected cells were harvested at different time
points.
Immunofluorescence microscopy
Cytocentrifuge smears ofthe cells were prepared and
incubated with a fluorescein-conjugated murine mono-
clonal antibody, directed against a common major outer
membrane protein (MOMP) epitope of elementary and re-
ticulate bodies. The samples were screened with an
epifluorescence microscope. Number of inclusion bodies
were counted and expressed as inclusion bodies/105 cells.
Infectivity, of Chlamgdia trachomatis
Infectivity of Chlamydia trachomatis was determined
by titration ofthe lysates ofinfected human monocytes and
THP-1 cells on Hep-2 cells using an indirect
immunoperoxydase assay (IPA). The number of inclusion
bodies/volume was expressed as inclusion forming units
perml (OFU/ml).
Molecular analyses of the chlamydial 16s rRNA gene
DNA and RNA were prepared from cell pellets, and
subjected to standard (screening) PCR or RT-PCR. For RT-
PCR reactions, I.tg RNA was reverse transcribed us-
ing the MuLV enzyme and the downstream primer. The
downstream primer used in all analyses was 30-mer
corresponding to bases +333 to +363
(5’CTGCAGCCTCCGTAGAGGTCTGGGCAGTGTC-3 ’)
The upstream primer used for standard PCR corre-
sponds to bases -103 TO -73 (5’-
AAGCTTTTcTTAAcAATGcAAATGAGATAG-3’) and
for the RT-PCR to nucleotides -66 TO -44 (5’-
GCCAGTATAGATGcTTGTGAGGA-3’) ofthe chlamy-
dial rRNA. Both upstream primers lie in a non-coding re-
gion unconserved in sequence except among serovars of
Chlamydia trachomatis. Products were analyzed on agar-
ose gels, and visualization of products was via ethidium
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bromide staining; positive/negative controls were included
in each assay.
Results
Infection ofhuman blood monocytes with Chlamy-
dia trachomatis was non-replicative as shown by titration
ofthe lysates ofthe infected monocytes on Hep-2 cells but
chromosomalDNA of Chlamydia trachomatis was present
during the whole culture period of 10 days when standard
PCR was performed on DNA preparations from infected
monocytes. To assess the viability of the intracellular
chlamydia, RT-PCR analyses were performed specific for
primary rRNA transcripts which are only producedby meta-
bolically active organisms. The presence of these primary
rRNA transcripts was demonstrated in monocytes from day
3 to day 10 post infection. Preparation of peripheral blood
monocytes does not exclude contamination with other
blood cells such as lymphocytes which are a known pro-
ducer of IFN’f. IFNy has been shown to induce persistent
chlamydial infection in human epithelial cells and fibro-
blasts via tryptophan degradation (3). Therefore, the hu-
man cell line THP-1 was used as a model for pure mono-
cytic cells. In contrast to human blood monocytes, inocula-
tion ofTPA-differentiated cells with Chlamydia trachomatis
resulted in low-productivity infection. During the culture
period of 10 days inclusion bodies were observed in 1-2%
ofthe THP-1 cells. Electron microscopic analyses revealed
the presence of single morphological atypical chlamydia
resembling those observed in human blood monocytes. By
preincubation with IFNq( the number of inclusion bodies
was reduced by 90% and the replicative infection was con-
verted into a non-replicative one. The number of inclusion
bodies and the infectivity was suppressed by IFNyin a dose
dependent manner. Chlamydial growth was completely in-
hibited at a concentration of 25U/ml IFNy. To prove the
presence of viable chlamydia after IFNy treatment within
the THP-1 cells IFNywas withdrawn at various times after
infection, resulting in a rise of the number of inclusion
bodies and of the infectivity.
Conclusions
So far viability of Chlamydia trachomatis has been
defined by detection of infectious organism, lack of infec-
tivity has been understood to mean non-viability. Our data
show that chlamydia infecting human blood monocytes
are viable within the host cell, even though the infection is
non-replicative and arrested at some point in their life cycle.
A similar state was induced by IFNy in chlamydia-infected
THP-1 cells. However, morphological atypical chlamydia
were also found in untreated infected THP-1 cells suggest-
ing that persistence of Chlamydia trachomatis is mediated
via IFNy-dependent and-independent mechanisms.
The presence of metabolically active chlamydia in
monocytes may contribute to the pathogenesis of chronic
chlamydial diseases via delivery of synthesized chlamy-
dial antigens inducing and/or sustaining the inflammatory
response.
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Introduction: Heat shock proteins (hsp) are induced
in cells after exposure to stressful stimuli, such as a tem-
perature increase or infection. During normal cell growth
these proteins are involved in essential cell functions such
as facilitating protein translocation across membranes, pro-
tein folding and binding to hormone receptors. Hsp have
been highly conserved during evolution, leading to struc-
tural and sequence homology between bacterial and hu-
man proteins in the same family. The adverse reproductive
sequelae of tubal infertility and ectopic pregnancy due to
C. trachomatis infection have been associated specifically
with an antibody response to the 60 kD chlamydial hsp. It
has also been shown, that the pregnancy rate after IVF in
women previously sensitized to the chlamydial hsp is mark-
edly reduced (1). Hsp have been classified according to
their molecular mass, as determined by sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
rather than by function. During acute and latent chlamy-
dial infections a variety of hsp are expressed by Chlamy-
dia, leading in susceptible patients to the development of
autoimmune phenomena (e.g. implantation failure). The aim
ofthis study was to immunolocalize possible binding sites
for crossreacting anti-hsp antibodies in the decidua of nor-
mal early human pregnancy. Therefore the distribution of
the 4 most common human hsp was analysed by immuno-
histochemistry.
Materials and Methods
Decidual tissue from 5 healthy normal pregnant
women undergoing elective termination ofpregnancy at 7-
11 weeks’ gestation was investigated. No evidence of in-
fection was found by clinical examination, bacterial cul-
tures and cervical Chlamydia DNA-probe testing. Fresh
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frozen decidual tissue sections were immunostained by the
avidin-biotin-peroxidase complex (ABC) method with
monoclonal antibodies against human hsp 27, hsp 60, hsp
72 and hsp 90 (Stressgen, Victoria B.C.). 3,3’
diaminobenzidene (Sigma, Munich, Germany) was used as
a chromogen. For negative control the primary antibody
was replaced with Tris-buffered saline and normal mouse
serum.
Table I. Distribution of heat shock proteins in human decidua
Cell type HSP27 HSP 60 HSP 70 HSP 90
Stromal cell +-+++ +/+ +-+++ +/-
(S/S) (3/s) (s/s)
Endometrial glands + +-++ ++/+++ +/-
(/s) (/s) (s/s)
Leukocytes +-+++ +/-
(S/S)
Numbers in parenthesis refer to the number of positive samples total
number of samples examined
Results
Decidual stromal cells stained for hsp 27 and hsp 72
in all cases, whereas staining for hsp 60 was seen in 3 cases.
The epithelium ofendometrial glands exhibited immunore-
activity for hsp 27 and hsp 60 in 2 and for hsp 72 in all
cases. Leukocytes were immunoreactive for hsp 72. Smooth
muscle cells in the wall ofblood vessels stained for hsp 60
in 3, and for hsp 72 in all cases. No unequivocal staining for
hsp 90 was seen. A summary of the results is illustrated in
table 1.
Discussion
Heat shock proteins are among the first major prod-
ucts ofzygotic gene activity in mouse embryogenesis, cor-
responding to a time of rapid development (2) Little is
known about the physiology of hsp expression in human
embryo development and early pregnancy. Controversy
surrounds the possible role of hsp in autoimmune disease,
because of the immunological similarity between micro-
bial and human hsp. It has been suggested that hsp may
provide a link between bacterial infection and the develop-
ment of autoimmune phenomena, resulting in infertility
and implantation failure (3). Here we present preliminary
data, demonstrating further evidence for a differentiated
expression of hsp in early pregnancy. Hsp 27, which has
been implicated as a regulator of actin cytoskeleton orga-
nization was found mainly expressed in decidual stromal
cells. This suggests that the regulation ofthe hsp 27 expres-
sion is different in decidual epithelial and stromal cells.
Hormonal factors, especially the elevated progesterone lev-
els in pregnancy, may be important in this respect. Studies
looking at the distribution ofhsp27 in endometrium ofpre-
menopausal women at different stages of their menstrual
cycle and endometrium from postmenopausal women re-
ceiving hormone replacement, indicated that hsp 27 is in-
creased by estrogen and inhibited by progesterone in glan-
dular epithelium but not stroma. (4) The intense staining
and widespread distribution ofhsp 60 and hsp 70 observed
in our study is consistent with current knowledge regard-
ing the essential role of these proteins in protein folding
and translocation between intracellular compartments. This
result also supports data by Tabibzadeh et al. who recently
showed the existence of the full complement of hsp in en-
dometrium of healthy women (5). In accordance with our
observations a similar hsp distribution profile and the de-
pendency ofhsp expression on endocrine parameters ofthe
menstruation cyclus was described. Hsp 90 which has been
related to interactions with protein substrates, including
steroid receptors was found nonspecifically distributed both
in stromal and epithelial cells. Whether this variable stain-
ing pattern is due to fluctuations in the systemic endocrine
milieu, inconsistencies in the applied technique, or to the
impact ofother factors remains to be determined. However,
growing evidence exists that chronic and/or repeated bac-
terial infections and excessive exposure to bacterial (e.g.
chlamydial) hsp can trigger immunity to hsp in the genital
tract. In this regard the crossreactivity between human and
mycobacterial and chlamydial hsp 60 has been most estab-
lished. Previous sensitization to the chlamydial hsp com-
bined with relative overproduction of human hsp during
the early stages of pregnancy may lead to reactivation of
hsp-sensitized lymphocytes and the subsequent induction
ofan inflammatory response. This will disturb immune regu-
latory mechanisms necessary for embryo implantation or
survival and may lead to immune rejection. Alternatively
decidual cell populations expressing human hsp can be-
come the target ofa humoral immune response. The human
decidua may therefore serve as target tissue for postulated
crossreacting anti-hsp antibodies.
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IsThere a Connection Between Immunity Response of
WomenWith Chlamydia trachomatis Infections of the
Genital Tract and Serum or Cervical Mucus Antiseminal
Antibodies?
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Protection, Donetsk, Ukraine
Introduction
Frequently immune reactions to different kinds of in-
vasion is the cause of aggression against gametes, their
physiological interaction and movement or against the
embryo. As known, infection ofthe genital tract is one fac-
tor leading to sensitization to sperm. Infectious agents may
play the role of trigger. Some ofthem have antigenic prop-
erties which are similar to those of spermatozo, this occurs
most frequently in STDs.
Objective
To establish the connection between the cell immune
response ofwomen with Chlamydia trachomatis infections
ofthe genital react and serum or cervical mucus antiseminal
antibodies.
Methods
Immunological status were determined by immunof-
luorescence with monoclonal antibodies to CD3
/(common
T-lymphocytes), CD4
/ (T-helper/inductors), CD8
/ (T-sup-
pressor/cytotoxic cells), 3F3
/ (B-lymphocytes) immune
cells. Blood samples were obtained by venipuncture from
105 women on the 25-27 day ofthe menstrual cycle. Iden-
tification of Chlamydia trachomatis was performed by im-
munofluorescence with monoclonal antibodies.
Antiseminal antibodies were determined in women’s serum
and cervical mucus by Friberg test, Shuvarsky test,
Kuretsrok-Muller test.
Results
32.2% ofthe women had Chlamydia trachomatis in-
fection of the genital tract during year; 56.6% of the
women had this infection during 2-4 years and 35.6% dur-
ing 5-7 years.
Persistent C. trachomatis in the genital tract during
5-7 years led to an increase in the relative quantity ofCD4+
by 7.45%, and a decrease ofCD8+ from 29.0% to 21.77%.
The measurement CD4:CD8 was increased by 54.5%. The
relative quantity of B-lymphocytes didn’t depend on in-
flammator duration.
Women with C. trachomatis infection of the genital
tract during 5-7 years were divided into two groups. Serum
and cervical mucus antiseminal antibodies were demon-
strated in 12 (33%) women with C. trachomatis genital in-
fection. They were described as being Group I. In Group II
there were 15 patients without antiseminal antibodies.
The inquiry of cell immunity in these two groups and
that of healthy women is demonstrated in Table 1.
The content of CD3+ cells in patients with C.
trachomatis and antiseminal antibodies (Group I) was lower
by 9.6% compared with those ofwomen without antiseminal
antibodies (Group II), andby 10% in those ofhealthywomen
(P<0.05). The contents of CD4+, CD8+ cells in Group I
were the same as they were in the other groups (P>0.05).
The measurement ofCD4:CD8 and relative quantity of3F3+
cells in women with C. trachomatis infection ofthe genital
tract and antiseminal antibodies were highest among these
three groups ofwomen (P<0.05).
Discussion
Recently scientific studies concerning the influence
of C. trachomatis on cell immunity have been published.
In some of them it was shown that genital infection in-
creased the immune response to seminal antigens
(Chernyshov VP., et al, 1990; 1993).
According to data received in our laboratory, persis-
tent C. trachomatis infection of the genital tract in women
over a long period (5-7 years), leads to changes the cell
immunity in some and leads to an increase in the relative
quantity ofT- and B-lymphocytes, and the measurement of
CD4:CD8. These immunological changes predispose pa-
tients to the development of antiseminal immunity.
Conclusion
Persistent C. trachomatis infection in the female geni-
tal tract with a duration of 5-7 years leads to a change in
cell immune responses which may cause the appearance of
antiseminal antibodies.
Table I. The content of CD3+, CD4+, CD8+, 3F3+ cells and measurement of CD4:CD8 of healthy
women and patients with genital Chlamydia trachomatis infection.
N Group CD3+ cells CD4+ cells CD8+ cells CD4:CD8 3F3+ cells
Group (n=12) 52.3+5.4 26.7+4.2 18.2+5.4 2.4+0.2 24.0+/-2.1
2 Group II (n=15) 61.9+/-3.5 32.3+/-5.5 23.7+/-4.2 1.4+/-0.4 15.8+/-3.1
3 Healthy women 63.2+/-4.2 30.2+/-5.1 20.8+/-4.8 1.2+/-0.3 12.2+/-2.8
(n=17)
P I-2 <0.05 >0.05 >0.05 <0.05 <0.05
P I-3 <0.05 >0.05 >0.05 <0.05 <0.05
P2-3 >0.05 >0.05 >0.05 >0.05 >0.05
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Habitual Abortion The Consequence of Immune
Response to Chlamydia trachomatis Infection of the Upper
Genital Tract inWomen
TMiroshnikova
Donetsk State Regional Centre ofthe Maternity and
Child Protection, Donetsk, Ukraine
Introduction
The interest of studying the effect of chlamydial in-
fection on the duration ofpregnancy and deliveries is such
because Chlamydia trachomatis as pathogenic agent is the
cause of 40-60% of infections of the upper genital tract.
Chlamydia trachomatis infects women during their repro-
ductive age and a period of intense sexual activity and
leads to prematurity and preterm deliveries. Under this con-
dition, chronic activation ofthe immune system in women
with Chlamydia trachomatis upper genital tract infection
may become a major mechanism of habitual abortion.
Objectives
To establish the role ofimmune response to Chlamy-
dia trachomatis upper genital tract infection inwomen with
habitual abortion.
Methods
Immunological status was determined by immunof-
luorescence with monoclonal antibodies to CD3+ (com-
mon T-lymphocytes), CD4+ (T-helpers/inductors), CD8+ (T-
suppressors/cytotoxic cells), 3F3+ (B-lymphocytes) immune
cells and by absorbable reaction with polyethelenglycole-
6000 in order to evaluate the maintenance ofimmune com-
plexes (IC). Blood samples were obtained by venipuncture
of 48 pregnant women with habitual abortion and chronic
genital chlamydiosis and 22 healthy ones in the st trimes-
ter.
Results
Two groups were comparedby age, marital status and
quantity ofsexual partners. 19.2% pregnantwomen with C.
trachomatis upper genital tract infection had abortion
before this pregnancy, 25.4% patients had 2 abortions and
25.4% women had 3 or more. Duration ofpelvic inflamma-
tory disease was year in 32.2% of women, during 2-4
years in 34.2% ofpatients and during 5-7 years in 35.6%.
According to our data, the physiologic course ofpreg-
nancy in Ist trimester was characterized by reduction of
absolute quantity ofCD3+, CD4+, and CD8+ cells and in-
crease of relative level of B-lymphocytes.
This condition of immunosuppression was stable in
pregnant women > 24 years old. In pregnant women age <
20 years, relative contents ofCD3+, CD4+, and CD8+ cells
were higher than those of nonpregnant women the same
age.
Pregnant women with C. trachomatis upper genital
tract infections had higher absolute (by 2 times) and rela-
tive quantity (19.6%) of B-cells and relative quantity of
CD3+ (12.61%). The measurement ofCD4/CD8 ofwomen
with genital Chlamydiosis was increased by 1.2 times over
those of healthy pregnant subjects.
In pregnant women with chronic Chlamydiosis the
relative contents of CD3+, CD4+, CD8+ lymphocytes in-
creased directly proportionally to age and did not depend
on the duration of the inflammatory process.
Relative level of CD3+, CD4+, CD8+
immunoregulator cells in pregnant subjects < 26 years of
age, with C. trachomatis upper genital tract infection was
higher than those of non pregnant subjects on the average
of25.5% (CD3+), 9.7% (CD4+), 12.6% (CD8+), and higher
than in healthy pregnant subjects by 15.2% (CD3+), 7.7%
(CD4+), 8.2% (CD8+).
Concentration of IC in blood serum of pregnant
women with C. trachomatis upper genital tract infection
was 40.93 condition units (cond.un.). It was higher than
healthy pregnant subjects on the average of48.3% cond.un.
The level ofIC in 16 year old pregnant subjects with
C trachomatis upper genital tract infection was 39.0 cond.
un., and was 47.3 cond. un with patients of36 years of age.
The content ofIC in blood serum ofpregnantwomen
with inflammatory process during 2-4 years was 38.5 cond.
un., and was 44.2 cond. un. if chronic Chlamydial infec-
tions persisted in upper genital tract during 5-7 years.
Discussion
The unusual changes revealed in T-cell subpopula-
tions oflymphocytes in women suffering from prematurity
with a background of genital Chlamydiosis during preg-
nancy has, inour opinion a double explanation.
First, populations ofCD8+ cells are heterogeneous. It
includes besides T-lymphocytes with suppressor activity,
cytotoxic cells and EK-cells. It is rather difficult to separate
functionally these populations (Barishnikov A.Y., et al.,
1989).
Cytotoxic cell [effector lymphocytes (T-killers) or
sensitized lymphocytes in old nomenclature] are able to
destroy target cells in the absence of specific antibodies
and complement.
As follows, T-killers influence allogeneic cells ofdo-
nors against which they are sensitized by previous intro-
duction of cells or tissue. As far as the interaction of T-
lymphocytes-killers with target cells containing appropri-
ate antigens is being executedby direct contact, this mecha-
nism is one of the basic reactions of transplant rejection-
that is the fetus (Vershigora A.E., 1990).
Thus, increase contents of CD8+ lymphocytes with
women with C. trachomatis infection ofupper genital tract
in Ist trimester of pregnancy is probably due to growth of
cytotoxic cells sensitized to the tissues of the fetus as an
allotransplant which is.clinically expressed by the threat of
pregnancy interruption or self abortion.
On the other hand, such high level ofCD8+ lympho-
cytes in pregnant women suffering from habitual abortions
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with a background ofchronic genital Chlamydiosis may be
explained by compensative changes in the immune system
in response to insufficient functional activity of T-suppres-
sors (CD8+ cells) which is confirmed by twice higher con-
tents of relative and absolute quantity of B-lymphocytes-
antibodies ofproducing cells at constant level ofT-helpers/
inductors (CD4+).
Conclusion
Chronic C. trachomatis upper genital infections in
pregnant women changes their immunological reactions
and may be the cause of habitual abortion.
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Serological crossreactions frequently occur between
the different species of Chlamydia such as C. trachomatis
and C. pneumoniae. Since a large proportion ofthe popula-
tion has been exposed to C. pneumoniae, the prevalence of
anti-Chlamydia antibodies is high and the differentiation
between C. pneumoniae and C. trachomatis specific anti-
bodies using conventional screening tests is not accurate.
To improve the diagnostic value of C. trachomatis serol-
ogy, SeroCT a C. trachomatis species-specific peptides-
based ELISA assay has been developed. All the peptides
which are used as antigen in SeroCT, originated from major
immunogenic proteins, have no homology with C.
pneumonaie yet, share sequence homology with all the 15
C. trachomatis serovars.
Table I. The prevalence of C. trachomatis antibodies as was
determined by SeroCT and MIF on different patients’
groups
Group & Overall
no. patients SeroCT+ MIF+ agreementa
IgG IgA IgG IgA IgG IgA
Arthritis (46) 53 34 56 46 88 82
Cervicitis+ (53) 82 26 87 53 100 9
Tubal infertility (36) 92 42 97 67 100 87
Adnexitis+ (i21) 100 48 100 52 100 86
+ Culture positive
a Overall agreement was calculated according to the agreement
between SeroCT and MIF FOR both positive and negative sera, while
sera that were positive on both C. trachomatis and C. pneumoniae
according to MIF (inconclusive interpretation of results) were
excluded.
SeroCT is highly specific as compared to different
MIF assays, see Figure 1. Specificity of above 90% was
Fig 1: Specificity of SeroCT as compared to 3 different MIF assays
-= 1501
,..o SeroCT
100-1
MIFI&2 are in house MIF references performed by 2 independent laboroes. SeroNA, a new
microimmunofluorescence assay for the differential
detection of C. trachomatis, C. pneumoniae, and C. psittaci.
Different groups of sera were screened by each MIF assay.
Fig 2: Sensitivity of SeroCT
as compared to culture
observed on sera with high prevalence of C. pneumoniae
antibodies according to MIF. The sensitivity of SeroCT on
a culture-positive population preselected by MIF, was 78%
for both IgG and IgA, see Figure 2. Out ofthe 22% sera that
were negative by SeroCT-IgG, 70% were also negative by
MIF. Moreover, on clinically defined populations (pelvid
inflammatory disease, cervicitis, arthritis, and tubal infer-
tility), high prevalence of IgG C. trachomatis antibodies
was observed in both SeroCT and MIF, as was expected. A
lower prevalence oflgA C. trachomatis antibodies was ob-
served in SeroCT as compared to MIF, probably due to the
residual cross reactivity ofthe antigen that is used in MIF.A
high overall agreement between SeroCT and MIF was ob-
served for both IgG (88/’o-100%) and IgA (82%-91%),
(Table 1).
The high specificity and sensitivity ofthe SeroCT for
the specific detection of C. trachomatis antibodies makes
this new generation test, an accurate, efficient and cost ef-
fective screening tool for the diagnosis of C. trachomatis
and its distinction from C. pneumoniae infections.
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Serum Antibodies to a Conserved B-Cell Epitope of
Chlamydial Heat Shock Protein 60 (hsp60) in Patients
with Sexually Acquired Reactive Arthritis (SARA)
K Domeika, SS Witkin, P-A Mrdh, and M
Domeika
1Institute of Clinical Bacteriology, Uppsala, Sweden,
2Department ofObstetrics and Gynecology, Cornell
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Objectives
Hsp60 is phylogenetically conserved and exhibits a
high degree of sequence homology between eucaryotic
cells, bacteria and within th C. trachomatis species (1). An-
tibodies to chlamydial hsp60 have been demonstrated in
C. trachomatis eye, respiratory- and genital tract infections
(2), as well as in patients with reactive arthritis having a
history ofprimary C. trachomatis infection (3). Stimulation
with a foreign antigen may elicit cross-reactivity with self-
antigens, (4) and lead to the local accumulation of heat
shock or stress proteins. This may provide the trigger for
immunopathologic processes such as arthritis, tissue dam-
age in salpingitis and scarfing in trachoma. Our study was
aimed at investigating the immune response to two syn-
thetic peptides corresponding to sequences of the chlamy-
dial hsp60 that are unique to this organism (amino acids
151-162) and conserved sequences that are also expressed
in the human hsp60 (amino acids 260-271), in patients with
SARA.
Materials and Methods
Thiry-nine samples from C. trachomatis
microimmunofluorescence (MIF) IgG antibody-positive
patients with diagnosed SARA were selected from the pre-
vious study (5). A criterion for the diagnosis, apart from
arthritis symptoms, was a direct immunofluorescence (DIF)
confirmed history of chlamydial genital tract infection
(urethritis in men, cervicitis in women), which had occurred
to 3 months before the onset ofarthritis symptoms. Twenty-
eight patients were DIF-positive and 11 DIF-negative. The
presence of antibodies against hsp60 were determined us-
ing an enzyme-linked immunosorbent assay (ELISA).
Results
Mapping of B-cell epitopes has demonstrated that
they consist of chlamydiae species and genus-specific
epitopes, as well as epitopes cross-reacting with human
hsp60 (6). In the present study IgG antibodies to unique
and conserved synthetic peptide epitopes of chlamydial
hsp60 were found in 7 (18%) and in 14 (35.9%) of the 39
SARA patients, respectively. All 7 samples with IgG anti-
body reactivity to peptide 151-162 also had antibodies to
peptide 260-271. The sera with antibodies to 151-162 and
260-271 did notmore often show MIF IgM or IgA antibody
reactivity, or higher antibody titres to C. trachomatis ofthe
Ig classes as compared to the hsp60-negative sera. How-
ever, only 4 samples were positive for IgA in MIF, which is
too few cases to allow for any reliable conclusion. IgM
antibodies were found in approximately 14% and 36%
among the hsp-positive and -negative sera, respectively.
Thus, half of the patients with antibodies to the hsp60
epitope that is conserved between chlamydiae and man did
not have antibodies to a chlamydia-specific hsp60 epitope.
This indicates that either the conserved epitope is more
immunogenic than the unique epitope following a chlamy-
dial infection or that some other microorganism might have
been the initial trigger for the induction of antibodies in
some SARA patients that are cross-reactive to the sequence
conserved in the chlamydial and human hsp60 molecules.
A positive DIF-test or the presence of neutralizing serum
antibodies also were not correlated with the presence of
hsp60 serum antibodies. Chlamydial antigen detection in
the urethra and in the cervix did not correlate with the pres-
ence of chlamydial hsp60 antibodies in patients with ReA
in a previous study (7), while in a second study the pres-
ence of antibodies to chlamydial hsp60 in patients with
non-gonococcal urethritis were correlated with the isola-
tion of C. trachomatis from the urethra (8). There was no
difference between the chlamydial hsp60 antibody-posi-
tive and-negative samples in the time lag between the diag-
nosis of a C. trachomatis infection and the onset ofSARA.
Conclusion
Futher work will be necessary to convincingly estab-
lish that auto-antibody responses to hsps play a signigicant
role in the immunopathology of chlamydial infection and
its sequelae, e.g., SARA.
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